These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8177045)

  • 1. Lipoprotein(a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia.
    Ritter MM; Geiss HC; Richter WO; Schwandt P
    Metabolism; 1994 May; 43(5):572-8. PubMed ID: 8177045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia.
    Bartens W; Rader DJ; Talley G; Brewer HB
    Atherosclerosis; 1994 Aug; 108(2):149-7. PubMed ID: 7980714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.
    Emanuele E; Peros E; Minoretti P; D'Angelo A; Piccinni MN; Montagna L; Geroldi D
    Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):193-9. PubMed ID: 15553596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipoprotein(a) levels differ in different phenotypes of primary hyperlipoproteinemia.
    Hiraga T; Okubo M; Kobayashi T; Nakanishi K; Sugimoto T; Murase T
    Metabolism; 1993 Oct; 42(10):1327-30. PubMed ID: 8412746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lp(a) concentration and apo(a) isoform size. Relation to the presence of coronary artery disease in familial hypercholesterolemia.
    Bowden JF; Pritchard PH; Hill JS; Frohlich JJ
    Arterioscler Thromb; 1994 Oct; 14(10):1561-8. PubMed ID: 7918305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.
    Milionis HJ; Efstathiadou Z; Tselepis AD; Bairaktari ET; Tsironis LD; Tsatsoulis A; Elisaf MS
    Thyroid; 2003 Apr; 13(4):365-9. PubMed ID: 12804105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.
    Kronenberg F; Kuen E; Ritz E; Junker R; König P; Kraatz G; Lhotta K; Mann JFE; Müller GA; Neyer U; Riegel W; Riegler P; Schwenger V; VON Eckardstein A
    J Am Soc Nephrol; 2000 Jan; 11(1):105-115. PubMed ID: 10616846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between lipoprotein A, apolipoprotein A and their isoforms in parents and children].
    Ferrer Lorente B; Dalmau Serra J; Falcó Couchoud C; Estellés Cortés A; España Furió F; Aznar Lucea J
    An Esp Pediatr; 1998 Jun; 48(6):587-92. PubMed ID: 9662841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of lipoprotein(a) and apolipoprotein(a) in plasma and lipoprotein fractions in the hypertriglyceridemic state.
    Reblin T; Hahn KR; Bethge F; Greten H
    Atherosclerosis; 1999 Jul; 145(1):71-9. PubMed ID: 10428297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study.
    Brown SA; Morrisett JD; Boerwinkle E; Hutchinson R; Patsch W
    Arterioscler Thromb; 1993 Nov; 13(11):1558-66. PubMed ID: 8218095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of remnant accumulation markers on plasma concentrations of two lipoprotein(a) subspecies (containing or free of apoE).
    Bach-Ngohou K; Giraud F; Krempf M; Bard JM
    Metabolism; 2001 Mar; 50(3):277-82. PubMed ID: 11230778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population.
    Werba JP; Safa O; Gianfranceschi G; Michelagnoli S; Sirtori CR; Franceschini G
    Atherosclerosis; 1993 Jul; 101(2):203-11. PubMed ID: 8379965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E; Solski J
    Ren Fail; 2002 Mar; 24(2):187-95. PubMed ID: 12071592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study.
    Brazier L; Tiret L; Luc G; Arveiler D; Ruidavets JB; Evans A; Chapman J; Cambien F; Thillet J
    Atherosclerosis; 1999 Jun; 144(2):323-33. PubMed ID: 10407493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
    Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
    Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of lipoprotein (a) levels and isoforms on fibrinolytic activity--study in families with high lipoprotein (a) levels.
    Falcó C; Estellés A; Dalmau J; España F; Aznar J
    Thromb Haemost; 1998 Apr; 79(4):818-23. PubMed ID: 9580386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein (a) levels, apolipoprotein (a) phenotypes and thyroid autoimmunity.
    Bairaktari ET; Tselepis AD; Millionis HJ; Elisaf MS
    Eur J Endocrinol; 1999 May; 140(5):474-6. PubMed ID: 10229916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
    Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T
    Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C; Rader D; Bartens W; Krämer J; Brewer HB; Schollmeyer P; Wieland H
    Ann Intern Med; 1993 Aug; 119(4):263-9. PubMed ID: 8328733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
    Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
    Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.